Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes,' new data in large B-cell lymphoma. "We ... are standardized." Terasawa and colleagues published their study in Leukemia & Lymphoma (Current clinical evidence on interim fluorine-18 fluorodeoxy glucose ...
2009 NOV 23 ... New research, 'Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma,' is ... a proportion of patients." Brown and colleagues published their study in Leukemia & Lymphoma (Prognostically significant cytotoxic T cell clones are stimulated after ...
2009 NOV 23 ... "Cell-based screening can facilitate the rapid identification of compounds inducing complex ... found that epidermal growth factor receptor (EGFR) inhibitors induce acute myeloid leukemia (AML) differentiation via a non-EGFR mechanism. In this report, we integrated proteomic ...
2009 NOV 23 ... Researchers detail in 'Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study,' new data in ... diffuse large B-cell lymphoma, follicular lymphoma, and B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Height was positively associated with risk of all B-cell ...
2009 NOV 23 ... frequency of FLI-1 immunoreactivity in a series of ALL cases and an expanded series of T-cell lymphoma subtypes," researchers in the United States report. ... "of CD45-negative acute lymphoblastic lymphoma/leukemia (ALL) immunoreactive for CD99 and Friend Leukemia Integration-1 (FLI-1) can occur and ...
2009 NOV 23 ... optimization of direct inhibition of the BCR-ABL kinase, inhibition of BCR-ABL-mediated cell growth via interruption of the BCR-ABL-mediated transcription, protein synthesis or ... Current study results from the report, 'Overcoming resistance in chronic myelogenous leukemia,' have been published. "Chronic myeloid leukemia is defined by the acquired genetic ...
2009 NOV 23 ... According to a study from Bologna, Italy, "Lipid signaling pathways are involved in cell growth, differentiation, and apoptosis, and could have a role in the progression of ... have a role in the progression of myelodysplastic syndromes (MDS) into acute myeloid leukemia (AML). Indeed, recent studies showed that phosphoinositide-phospholipase (PI-PL) Cbeta1 ...
2009 NOV 23 ... patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma,' are detailed in a study published in Leukemia & Lymphoma. "Young patients ...
2009 NOV 23 ... to selectively kill drug-resistant cells over parent cancer cells. 5q inhibits tumor cell growth through the induction of apoptosis, with detailed mechanism of its selectivity ... HA 14-1), mitigates drug resistance and synergizes with a variety of cancer therapies in leukemia cells. Structure-activity relationship (SAR) studies of 5a guided the development of ...
2009 NOV 23 ... study, 'Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand,' is now ... do we stand,' is now available. According to recent research published in the journal Leukemia & Lymphoma, "Interim 18F-fluorodeoxyglucose positron emission tomography performed ...
2009 NOV 23 ... Investigators publish new data in the report 'Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.' According to recent research from ... and aggressive disease." Kohrt and colleagues published their study in Leukemia & Lymphoma (Extranodal natural killer/T-cell lymphoma: current concepts in biology and ...
2009 NOV 23 ... 6 of 10 miRNA promoters examined showed gain of methylation compared with normal B-cell controls. Subsequent target prediction of deregulated miRNAs revealed a highly ... if deregulated, in the development of neoplastic disorders including chronic lymphocytic leukemia (CLL). RNAs from primary cells of 50 treatment-naive CLL patients and peripheral B cells ...
2009 NOV 27 ... that goal for a protein with major roles in cancer, cardiovascular disease and stem cell biology."If human physiology is like a puppet show, then transcription ... in patients with a form of blood cancer, known as T-ALL or T-cell acute lymphoblastic leukemia.Abnormal NOTCH genes found in cancer patients remain in a state of constant ...
2009 NOV 23 ... "In the current study, we examined the miRNAs perturbed in CD138 positive MM cell lines and CD138 positive primary MM cells, using microarray analysis and quantitative ... miRNA signature in MM." Unno and colleagues published their study in Leukemia & Lymphoma (Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma. ...
2009 NOV 23 ... Researchers detail in 'Early detection of patients with poor risk diffuse large B-cell lymphoma,' new data in large B-cell lymphoma. "More than 60% of patients with diffuse ... to ensure ongoing relevance." Sehn and colleagues published their study in Leukemia & Lymphoma (Early detection of patients with poor risk diffuse large B-cell lymphoma. ...
2009 NOV 23 ... A report, 'Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism ... from GVHD, but does not portend disease recurrence,' is newly published data in Leukemia & Lymphoma. "We analyzed the kinetics of CD3 chimerism in 120 consecutive allogeneic ...
2009 NOV 23 ... in the progression of HCC. DPT mRNA expression was analyzed in normal tissues and HCC cell lines by RT-PCR, and in HCC tissue by RT-PCR and real-time PCR. Its protein was examined ... pathway. MCTx-1 from Millepora, a homolog of DPT, is identified as a cytotoxin towards leukemia cells." "The aim of this study was to analyze DPT expression in ...
2009 NOV 23 ... effect of Trubion's Tru-ADhanCe™ technology in promoting enhanced natural killer cell mediated cytotoxicity against primary CLL cells. TRU-016 is Trubion's novel ... 1) an ongoing Phase 1 clinical trial of TRU-016 for the treatment of chronic lymphocytic leukemia (CLL), and 2) a preclinical study demonstrating the effect of Trubion's ...
